AI Tool Comparison
Comparing as AI Medical Imaging & DiagnosticsDAX Copilot vs Viz.ai
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
DAX Copilot
VS
Viz.ai
Verdict by Category
AI content generation failed. Refresh the page to try again.
Detailed Comparison
Feature
DAX Copilot
Viz.ai
Pricing
CustomMicrosoft does not publish self-serve pricing for DAX Copilot / Dragon Copilot; access is sold through Microsoft sales or authorized Cloud Solution Provider resellers, and pricing has varied significantly by channel and date. For years, authorized resellers commonly quoted $369-$830+ per provider per month plus a one-time setup fee (often around $650-$700), depending on contract size and minimum term. In a May 2026 marketplace restructuring, Microsoft published tiered list pricing including a Flex plan at roughly $604.80 per user per month (base license plus pay-as-you-go ambient use) and a higher uncapped Per-User tier around $1,512 per user per month (itself a 57% cut from a prior list price). A lower-cost "Physician Practice" license aimed at 5-50 clinician offices was briefly offered via the CSP channel at roughly $150-$160 per user per month before reaching end-of-sale on May 1, 2026. Large health systems negotiating volume, multi-year contracts frequently report effective rates well below these list prices. There is no public free trial for individual purchase, though Microsoft runs structured 30-90 day enterprise pilot programs for qualifying health systems.
CustomViz.ai operates exclusively on custom enterprise contracts with hospitals, health systems, and imaging networks. There is no published pricing or self-serve access.
Pricing is negotiated based on hospital type, imaging volume, number of conditions covered, and multi-site deployment needs. Viz.ai's Medicare NTAP designation provides hospitals with an additional reimbursement of approximately $1,040 per qualifying patient encounter, partially offsetting platform costs.
Contact Viz.ai through viz.ai to schedule a demo and begin enterprise procurement discussions.
Categories
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
AI Healthcare ToolsAI Research & Education Tools
Summary
Microsoft's enterprise ambient AI for physicians, nurses, and radiologists — formerly Nuance DAX
AI care coordination platform for stroke, PE, and aortic disease — FDA-cleared algorithms alerting care teams in minutes
DAX Copilot Pros & Cons
Pros
- Broadest role coverage of any major ambient AI platform, spanning physicians, nurses, and radiologists in one product family
- Deepest, longest-running Epic integration in the category, built on two decades of Dragon speech technology
- Backed by Microsoft's security, compliance (HITRUST, SOC 2 Type II), and Azure infrastructure at massive scale
- Extensible via a Developer Kit and third-party app marketplace rather than a closed, single-vendor tool
- Strong, publicly documented customer outcomes (time-in-note reductions, added appointments) across large health systems
- Available across multiple countries for physicians, with continued regional expansion
Cons
- No public pricing; buyers must go through Microsoft sales or a reseller, and quoted rates vary enormously (roughly $150 to $1,500+ per provider per month across sources)
- No self-serve signup or public free trial, unlike most consumer-facing AI scribes; enterprise procurement is required even for small practices
- Historically the most expensive mainstream ambient scribe, which prices out solo clinicians and small independent practices
- EHR write-back connectors for non-Epic systems are sometimes a separate, additional cost arranged through third-party partners
- Nurse and radiologist experiences have more limited geographic availability (US-only, with radiology still in preview) than the physician product
Viz.ai Pros & Cons
Pros
- 12 FDA-cleared algorithms — broadest acute-condition AI portfolio in its class
- Medicare NTAP reimbursement pathway — unique among AI imaging platforms
- 44% reduction in DIDO times for stroke patients — peer-reviewed clinical evidence (ISC 2026)
- 1,000+ hospital deployments across U.S. and Europe
- Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
- Simultaneous mobile alerts to full care team — no phone-tag delays
- Expands from neurology to cardiology and pulmonology in one unified platform
Cons
- Enterprise-only pricing — no self-serve or small clinic access
- No published pricing — all contracts are custom
- Primarily focused on acute/time-sensitive conditions — not general radiology reads
- Requires integration with existing hospital imaging infrastructure
- Implementation and onboarding take time for large multi-site systems